Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Geneial

Created a decentralized worldwide network of genomic biobanks that connects biobanks to each other and to researchers
2020
02-Oct
02-10
Houston, Texas, United States
  • Drug Discovery and Development
  • Pathology & Diagnostics
  • Personalized Medicine Technologies
  • Services (Patient care)

Innovation

Industry Problem

Genomic and biomarker data are complex and are not consistently converted into clear, patient-specific diagnostic or treatment decisions.

R&D Focus

Genomics and multi-omics for patient stratification and treatment selection

Innovative Solution

Through private data exchange, Geneial accelerates precision medicine. It seeks to alleviate human suffering by establishing a decentralized global network of genomic biobanks that connects biobanks to one another and to researchers.

Investment Funding

Last Funding Stage

Grant

Total Funding Amount

2.3M

Last Funding Date

01-11-2023

Startup Stage

Seed

Lead Investors

National Human Genome Research Institute, Campus Founders Fund, National Library of Medicine

Revenue

$1M to $10M

About

Through private data exchange, Geneial accelerates precision medicine. It seeks to alleviate human suffering by establishing a decentralized global network of genomic biobanks that connects biobanks to one another and to researchers.

Something missing or incorrect on this page? Help us enrich this information